Skip to main content
. 2015 Jan 29;11(6):4158–4164. doi: 10.3892/mmr.2015.3276

Figure 5.

Figure 5

In vivo growth inhibition of implanted NPC-039 nasopharyngeal carcinoma cells in nude Balb/c mice by matrine. NPC-039 cells were implanted subcutaneously into nude mice. Mice were treated with or without matrine by intraperitoneal injection (60 mg/kg/day). (A) The relative tumor volume and (B) final tumor weight of control and matrine-treated mice impanted with NPC-039 cells. *P<0.05 and **P<0.01, compared with vehicle treatment.